Daivonex 50 mikrogram/g salve Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

daivonex 50 mikrogram/g salve

leo pharma a/s - calcipotriol - salve - 50 mikrogram/g

Delcibet 50+500 mikrogram/g salve Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

delcibet 50+500 mikrogram/g salve

leo pharma a/s - betamethasondipropionat, calcipotriol hydrate - salve - 50+500 mikrogram/g

Enstilar 50 mikrog/g+0,5 mg/g kutanskum Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

enstilar 50 mikrog/g+0,5 mg/g kutanskum

leo pharma a/s - betamethasondinatriumphosphat, calcipotriol - kutanskum - 50 mikrog/g+0,5 mg/g

Fucidin imprægneret gaze Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

fucidin imprægneret gaze

leo pharma a/s - natriumfusidat - imprægneret gaze

Heparin "Leo" 5.000 IE/ml injektionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

heparin "leo" 5.000 ie/ml injektionsvæske, opløsning

orifarm a/s - heparinnatrium - injektionsvæske, opløsning - 5.000 ie/ml

Pifeltro Europeiska unionen - danska - EMA (European Medicines Agency)

pifeltro

merck sharp & dohme b.v. - doravirine - hiv infektioner - antivirale midler til systemisk anvendelse - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

Heparin LEO 1.000 IE/ml injektionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

heparin leo 1.000 ie/ml injektionsvæske, opløsning

orifarm a/s - heparinnatrium - injektionsvæske, opløsning - 1.000 ie/ml

Heparin LEO 100 IE/ml injektionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

heparin leo 100 ie/ml injektionsvæske, opløsning

paranova danmark a/s - heparinnatrium - injektionsvæske, opløsning - 100 ie/ml

Kaftrio Europeiska unionen - danska - EMA (European Medicines Agency)

kaftrio

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cystisk fibrose - andet respirationssystem produkter - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Pirfenidone axunio (previously Pirfenidone AET) Europeiska unionen - danska - EMA (European Medicines Agency)

pirfenidone axunio (previously pirfenidone aet)

axunio pharma gmbh - pirfenidon - idiopatisk lungefibrose - immunosuppressiva - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).